Consequently, research into the relationship between EGFR mutation status and radiological features of brain metastases has become a focal point, with efforts to improve qualitative and quantitative diagnosis, differential diagnosis, tumor grading and staging, molecular typing, and evaluation of treatment efficacy in intracranial tumors (29–31). This evidence concerns the gene EGFR and neoplasm.